Section Arrow
Quote
DAWN.NASDAQ
- Day One Biopharmaceuticals
Quotes are at least 15-min delayed:2026/03/09 15:38 EDT
Regular Hours
Last
 21.295
+0.085 (+0.40%)
Day High 
21.3 
Prev. Close
21.21 
1-M High
21.23 
Volume 
9.06M 
Bid
21.29
Ask
21.3
Day Low
21.19 
Open
21.19 
1-M Low
9.97 
Market Cap 
2.19B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 12.32 
20-SMA 11.93 
50-SMA 11.06 
52-W High 21.23 
52-W Low 5.635 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.04/0.10
Enterprise Value
2.19B
Balance Sheet
Book Value Per Share
4.27
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
158.18M
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ANTXAN2 Therapeutics5.26+2.42+85.21%-- 
IBRXImmunityBio8.4915-0.1585-1.83%-- 
IOVAIovance Biotherapeutics5.425+0.29+5.65%-- 
RLMDRelmada Therapeutics7.16+2.71+60.90%-- 
QNCXQuince Therapeutics0.1076+0.0053+5.18%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY301 is an antibody drug conjugate (ADC) that has shown antitumor activity in preclinical models.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.